Global Biopharmaceutical Logistics Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Biopharmaceutical Logistics Market size is projected to experience significant growth from 2019 to 2025.
 

The rising number of biosimilar approvals around the world, growing trend of outsourcing logistics and growth in pharmaceutical distribution network owing to its sales numbers are some of the factors that are impelling the growth of the biopharmaceutical third party logistics market. According to the news published in Generics and Biosimilars Initiative, the European Commission and the European Medicine Agency in 2017, have approved around 18 biosimilars. Hence, owing to these approvals of biosimilars, the market is expected to witness a significant growth over the forecast period.
 

With rapid technological advancements in logistics is also boosting the growth of the market. Technologies such as data mining, mobile cloud solutions, and real time monitoring are the factors that have contributed into the growth of the market positively. Furthermore, these monitoring solutions assist the logistic companies by providing alerts in order to procure information to execute contingency plans. Hence, the adoption of these solutions is expected to boost the growth of the market in the upcoming years.
 

Growing upsurge in the production of biologics, vaccine, hormone treatments and complex proteins that require cold chain shipment has further propelled the growth of the market. Hence, transportation and delivery of pharmaceutical products that require a specific temperature witnessed a considerable growth of biopharmaceutical logistics market. Furthermore, the growing demand for outsourcing transportation services has significantly grown over the past one decade. This is due to various bio pharma companies are undergoing an agreement or outsourcing logistics to service providers in order to reduce the overall operating cost that has in turn lower down the pharmaceutical products. Thus, all these developments have uplifted the growth of the biopharmaceutical logistics market.
 

However, high operational cost in order to maintain temperature sensitive products may restrict the overall growth of the market in the future years.
 

Cold chain logistics is expected to witness the significant growth over the forecast period. This is attributed to the rising demand for biologics over the past one decade that require temperature-controlled distribution. Moreover, growing demand for cellular therapies, vaccines and blood products are further driving the growth of the market.
 

Warehouse and storage are expected to witness the lucrative growth over the forecast period. This is owing to reduce the operating cost; the biopharmaceutical companies are moving towards the logistic companies.
 

North America is currently dominating the biopharmaceutical logistics market in the region. This is attributed to the couple of factors such as large number of export and import of pharmaceuticals and large number of pharmaceutical drugs and biologics market in the region. Furthermore, growing advancements in warehousing & transportation and rising adoption of advanced technologies ae some of the factors that are boosting the growth of the market.
 

Asia Pacific is expected to witness the lucrative growth over the forecast period. This is attributed to the growing demand for medicines among aging population and growing number of diseases in the region is contributing to the rising demand for pharmaceuticals and biologics are further contributing into the growth of the market.
 

Few of the key companies operating in biopharmaceutical logistics market include FedEx., DHL International GmbH, SF Express, United Parcel Service of America, Inc., AmerisourceBergen Corporation, DB Schenker, KUEHNE + NAGEL, Kerry Logistics Network Limited and Agility. key companies in the market are undergoing collaborations, and partnerships in order to expand their presence due to fragmentation of the market. For instance, DHL established a new iOS and Android app, name LifeTrack that enable its users to access the online tracking platform for cold chain shipments to provide the life science and healthcare shippers an overview of their shipments.
 

Biopharmaceutical Logistics Market by Supply Chain, 2014-2025 (USD Million)

• Cold chain logistics
• Non-cold chain logistic

Biopharmaceutical Logistics Market by Service Type, 2014-2025 (USD Million)

• Transportation
  • Air freight
  • Sea freight
  • Overland transportation
• Warehouse and storage

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia

Company Profiles:

• FedEx
• DHL International GmbH
• SF Express
• United Parcel Service of America, Inc.
• AmerisourceBergen Corporation
• DB Schenker
• KUEHNE + NAGEL
• Kerry Logistics Network Limited
• Agility

What Information does this report contain?